Clinical Trial Update: Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC) [Phase 2]

View source ↗

Summary

Phase II trial evaluating the addition of Avelumab to chemotherapy as perioperative treatment for patients with resectable gastric cancer or gastroesophageal ju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Adenocarcinoma
• Stomach Neoplasms

Drugs mentioned

• Avelumab (avelumab)
• Chemotherapy (unspecified regimen)

Snippet

Sponsor: Vall d'Hebron Institute of Oncology | Conditions: Gastroesophageal Junction Adenocarcinoma, Stomach Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING